[Clinical evaluation of penimepicycline in gynecology and obstetrics].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002585:Cesarean Section; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007044:Hysterectomy; D017053:Infection Control; D007273:Injections, Intramuscular; D008413:Mastitis / Q000188:drug therapy; D008431:Maternal-Fetal Exchange; D008892:Milk / Q000032:analysis; D010403:Penicillin Resistance; D010404:Penicillin V / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D051381:Rats; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013752:Tetracycline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D013752:Tetracycline; D010404:Penicillin V